May 30, 2023

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

April 29, 2023

A TAILORx post hoc analysis is the first to show racial and ethnic differences in locoregional breast cancer recurrence

April 28, 2023

JAMA Surgery publishes TAILORx analysis showing that racial and ethnic differences in locoregional breast cancer recurrence patterns are prevalent even in a clinical trial population with similar access to care

April 26, 2023

Two new studies shed light on cancer detection in dense breasts as researchers emphasize the need for the TMIST trial

April 7, 2023

American College of Radiology (ACR) leader highlights TMIST mammography trial in testimony supporting NIH funding increase

February 27, 2023

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

January 5, 2023

The Winter 2023 advocacy blog Considering Clinical Trials is now available

December 13, 2022

HealthDay News informs the public of the 12-year TAILORx results

December 6, 2022

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

ECOG-ACRIN Cancer Research Group